Biosynthetic Luminescent Ag Nanoparticles in Functionalization for Breast Cancer Therapy

Qiong Hu,Zhenzhu Wang,Chong Fan,Qing Wang,Ting Luan,Aiwen Wu,Zhichong Wang,Xianyun Hu,Gen Zhang,Ting Wang,Qing Li

DOI: https://doi.org/10.1166/jbn.2022.3361

2022-01-01

Journal of Biomedical Nanotechnology

Abstract:Breast cancer is still the most common malignant tumor in the world despite the research and technique advances. However, how to come true targeted controlled release perplexing the clinicians all the time and rapid development of nanotechnology, as well as emerging microRNA (miRNA), offers an opportunity for diagnosis and treatment of breast cancer. Here, nude mouse model with breast cancer was built and silver nanoparticles (Ag-NPs, ANPs) with near infrared characteristic were biosynthesized. Then, RNA-seq, western blot analysis, and immunofluorescence of the differential expression spectrum of cultured mouse T cells treated by silver nitrate in vitro hinted that biosynthesis of ANPs in cells depended on participation of ferritin and serum albumi(SA). Subsequently, ANPs loaded with miR-200c (miR-P: 846247 10 On: Mon 31 Oct 2022 07:42:05 200c@ANPs) in vivo and in vitro showed its well propty of intelligent controlled elease, function of targeted imaging, Copy ight American Scientific Publishers and potential targeted therapy. The present dataDeliverindicatedbythatIngentabiosynthesized miR-200c@ANPs was equipped with biocompatibility, intelligent controlled release drug, tumor targeting therapy, as well as the visual function. More, this method may be a promising alternative option for diagnosis and treatment of breast cancer.